Boswellia, the resin extract from the frankincense tree, is primarily used to reduce inflammation. Its active compounds block a specific enzyme involved in producing inflammatory molecules in the body, making it a popular supplement for joint pain, arthritis, and certain digestive conditions. Clinical trials have used doses up to 1,000 mg daily for as long as six months with a good safety profile.
How Boswellia Reduces Inflammation
The resin contains a group of compounds called boswellic acids, with one in particular standing out for its potency. This compound directly blocks an enzyme called 5-lipoxygenase, which your body uses to produce leukotrienes, molecules that drive swelling, pain, and tissue damage. Unlike common anti-inflammatory drugs that work through a different pathway (the COX pathway), boswellia targets this leukotriene route, which plays a role in conditions ranging from arthritis to asthma.
Beyond that single enzyme, boswellic acids also suppress a master switch for inflammation called NF-kB. When this switch is active, it triggers the release of a cascade of inflammatory signals throughout the body. By dialing it down, boswellia can reduce levels of multiple inflammatory molecules at once, including TNF-alpha and several interleukins that contribute to chronic pain and tissue breakdown.
Joint Pain and Arthritis
This is the most well-supported use for boswellia. In arthritis, the immune system attacks joint tissue, triggering enzymes that break down cartilage, collagen, and the cushioning fluid between joints. Lab research on a standardized boswellia extract (containing at least 30% of the most active boswellic acid) showed significant inhibition of collagenase, elastase, and hyaluronidase, three enzymes directly responsible for degrading joint structures. The extract also reduced the production of reactive oxygen species that accelerate cartilage damage.
For people with osteoarthritis, this translates to less stiffness, reduced swelling, and improved mobility. Boswellic acids appear to suppress the innate immune response in joint cells specifically, calming the signaling pathways that perpetuate the cycle of inflammation and tissue destruction. Many people use boswellia alongside conventional treatments, though it works through a distinct mechanism that complements rather than duplicates what standard anti-inflammatory medications do.
Digestive Conditions
Boswellia has drawn interest for inflammatory bowel diseases like ulcerative colitis and Crohn’s disease, but the evidence here is mixed. A randomized, placebo-controlled trial for maintaining Crohn’s disease remission was actually terminated early because the supplement performed no better than placebo. About 60% of the actively treated patients stayed in remission compared to 55% in the placebo group, a difference that was not statistically meaningful. Time to relapse, quality-of-life scores, and lab markers of inflammation also showed no advantage.
Some smaller or less rigorous studies have reported modest benefits for ulcerative colitis, but the Crohn’s data serves as an important reality check. If you’re considering boswellia for a serious digestive condition, it’s worth knowing that the strongest trial to date found no benefit over placebo for keeping symptoms at bay.
Respiratory and Immune Effects
Because leukotrienes play a central role in asthma (they cause airway narrowing and mucus production), researchers have tested boswellia for allergic airway inflammation. Animal studies using oral boswellia supplementation during asthma sensitization found significantly reduced airway inflammation, fewer immune cells flooding the lungs, and lower levels of the immune signals that drive allergic reactions. Interestingly, the benefit appeared to work partly through changes in gut bacteria. Oral boswellia increased populations of a beneficial bacterial species, and when researchers gave that bacterium alone, it also reduced airway inflammation.
Human data on asthma is still limited, and the animal findings, while promising, don’t guarantee the same results in people. That said, the leukotriene-blocking mechanism is the same one targeted by prescription asthma medications, which gives the research a plausible biological foundation.
Absorption and What to Look For
Boswellic acids are poorly absorbed on their own, which has historically limited their effectiveness. A clinical crossover study comparing a standard boswellia extract to a lecithin-based formulation found that the lecithin version delivered significantly higher and faster absorption of most boswellic acids, reaching blood levels in the range needed to actually interact with their inflammatory targets. Standard extracts often produce blood levels too low to have a meaningful effect, which may explain why some trials show weaker results than expected.
When shopping for supplements, look for products standardized to contain a specified percentage of boswellic acids. Higher-end extracts are standardized to at least 30% of the most active compound. Lecithin-based or phytosome formulations are worth considering if absorption is a concern, as they represent a meaningful improvement over conventional extracts.
Dosage and Safety
Clinical trials have used boswellia extract at up to 1,000 mg per day for six months without significant safety concerns, according to the National Center for Complementary and Integrative Health. Short-term use at doses as high as 2,400 mg daily for up to one month also appears safe. Side effects are uncommon and typically mild when they occur.
One important caution: boswellia may increase bleeding risk if you take blood thinners like warfarin. Memorial Sloan Kettering Cancer Center flags this interaction specifically. For pregnant or breastfeeding women, boswellia in food amounts is considered safe, but there isn’t enough data to confirm safety at supplemental doses. Topical use and aromatherapy with frankincense (the same resin in essential oil form) are also generally considered safe.